Certified by Founder Lodge
Pivotal bioVenture Partners
United States - SAN FRANCISCO, California
INVESTOR
1 Disclosed Funding Rounds $50,000,000
3 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Pivotal bioVenture Partners (U.S.), an affiliate of Pivotal Life Sciences
We back the brightest minds in life sciences.
Our seasoned investment team brings over 50 years combined biotec
| Company | Date | Round | Raised |
|---|---|---|---|
Evommune |
April, 27 ,2023 | Series B | $50,000,000 |
Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
Mosanna Therapeutics |
June, 10 ,2025 | Series A | $80,000,000 |
Evommune
Avalyn Pharma Inc.
Mosanna Therapeutics
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Standard Kernel Co. | $20,000,000 | (Mar 12, 2026)
Sigma360 | $17,000,000 | (Mar 11, 2026)
PactFi | $25,000,000 | (Mar 11, 2026)
Lux Aeterna | $10,000,000 | (Mar 11, 2026)
Axiom Trust Company | $11,800,000 | (Mar 11, 2026)